PD‐L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD‐L1‐low and ‐negative patients with non‐small cell lung cancer
Nadja Schöne(University of Münster), Annalen Bleckmann(Universitätsmedizin Göttingen)
Cited by 26
Related Papers
Ror2 Signaling and Its Relevance in Breast Cancer Progression
|Frontiers in Oncology|2017|58
Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas
|Clinical & Experimental Metastasis|2012|47
β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases
|Clinical & Experimental Metastasis|2016|42